Annual SGA
$14.09 M
+$1.81 M+14.76%
December 31, 2023
Summary
- As of February 7, 2025, LRMR annual SGA is $14.09 million, with the most recent change of +$1.81 million (+14.76%) on December 31, 2023.
- During the last 3 years, LRMR annual SGA has risen by +$2.69 million (+23.61%).
- LRMR annual SGA is now at all-time high.
Performance
LRMR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$4.34 M
-$572.00 K-11.63%
September 30, 2024
Summary
- As of February 7, 2025, LRMR quarterly SGA is $4.34 million, with the most recent change of -$572.00 thousand (-11.63%) on September 30, 2024.
- Over the past year, LRMR quarterly SGA has dropped by -$572.00 thousand (-11.63%).
- LRMR quarterly SGA is now -11.63% below its all-time high of $4.92 million, reached on June 30, 2024.
Performance
LRMR Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$856.93 M
-$64.77 M-8.18%
September 30, 2024
Summary
- As of February 7, 2025, LRMR TTM SGA is -$856.93 million, with the most recent change of -$64.77 million (-8.18%) on September 30, 2024.
- Over the past year, LRMR TTM SGA has dropped by -$872.91 million (-5462.52%).
- LRMR TTM SGA is now -3604.53% below its all-time high of -$23.13 million.
Performance
LRMR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
LRMR Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.8% | -11.6% | -5462.5% |
| 3 y3 years | +23.6% | -11.6% | -5462.5% |
| 5 y5 years | +481.2% | -11.6% | -5462.5% |
LRMR Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.7% | -11.6% | +55.5% | -119.0% | at low |
| 5 y | 5-year | at high | +481.2% | -11.6% | +477.8% | -3604.5% | at low |
| alltime | all time | at high | +481.2% | -11.6% | +654.3% | -3604.5% | at low |
Larimar Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.34 M(-11.6%) | $16.57 M(+3.7%) |
| Jun 2024 | - | $4.92 M(+29.6%) | $15.98 M(+7.9%) |
| Mar 2024 | - | $3.79 M(+8.0%) | $14.81 M(+5.1%) |
| Dec 2023 | $14.09 M(+14.8%) | $3.51 M(-6.4%) | $14.09 M(+2.1%) |
| Sep 2023 | - | $3.75 M(+0.2%) | $13.79 M(+6.3%) |
| Jun 2023 | - | $3.75 M(+21.8%) | $12.97 M(+5.7%) |
| Mar 2023 | - | $3.08 M(-4.5%) | $12.27 M(-0.0%) |
| Dec 2022 | $12.28 M(+1.7%) | $3.22 M(+9.9%) | $12.28 M(+3.6%) |
| Sep 2022 | - | $2.93 M(-3.7%) | $11.85 M(+2.0%) |
| Jun 2022 | - | $3.04 M(-1.2%) | $11.62 M(-3.3%) |
| Mar 2022 | - | $3.08 M(+10.3%) | $12.02 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $12.07 M(+5.9%) | $2.79 M(+3.4%) | $12.07 M(-7.8%) |
| Sep 2021 | - | $2.70 M(-21.5%) | $13.10 M(-5.2%) |
| Jun 2021 | - | $3.44 M(+9.9%) | $13.81 M(+7.4%) |
| Mar 2021 | - | $3.13 M(-18.1%) | $12.86 M(+12.9%) |
| Dec 2020 | $11.40 M(+370.2%) | $3.82 M(+11.9%) | $11.40 M(+36.9%) |
| Sep 2020 | - | $3.42 M(+37.1%) | $8.33 M(+51.3%) |
| Jun 2020 | - | $2.49 M(+49.5%) | $5.50 M(+53.4%) |
| Mar 2020 | - | $1.67 M(+121.7%) | $3.59 M(+86.7%) |
| Dec 2019 | $2.42 M | $752.00 K(+26.6%) | $1.92 M(+64.3%) |
| Sep 2019 | - | $594.00 K(+3.1%) | $1.17 M(+103.1%) |
| Jun 2019 | - | $576.00 K | $576.00 K |
FAQ
- What is Larimar Therapeutics annual SGA?
- What is the all time high annual SGA for Larimar Therapeutics?
- What is Larimar Therapeutics annual SGA year-on-year change?
- What is Larimar Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly SGA year-on-year change?
- What is Larimar Therapeutics TTM SGA?
- What is the all time high TTM SGA for Larimar Therapeutics?
- What is Larimar Therapeutics TTM SGA year-on-year change?
What is Larimar Therapeutics annual SGA?
The current annual SGA of LRMR is $14.09 M
What is the all time high annual SGA for Larimar Therapeutics?
Larimar Therapeutics all-time high annual SGA is $14.09 M
What is Larimar Therapeutics annual SGA year-on-year change?
Over the past year, LRMR annual SGA has changed by +$1.81 M (+14.76%)
What is Larimar Therapeutics quarterly SGA?
The current quarterly SGA of LRMR is $4.34 M
What is the all time high quarterly SGA for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly SGA is $4.92 M
What is Larimar Therapeutics quarterly SGA year-on-year change?
Over the past year, LRMR quarterly SGA has changed by -$572.00 K (-11.63%)
What is Larimar Therapeutics TTM SGA?
The current TTM SGA of LRMR is -$856.93 M
What is the all time high TTM SGA for Larimar Therapeutics?
Larimar Therapeutics all-time high TTM SGA is -$23.13 M
What is Larimar Therapeutics TTM SGA year-on-year change?
Over the past year, LRMR TTM SGA has changed by -$872.91 M (-5462.52%)